Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events

Posted on August 21st, 2017 by in Pharma R&D

High-quality compound bioactivity data and information about biological pathways and potential drug targets is more readily available than ever—and in enormous amounts that are often daunting to researchers Continue reading “Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events” »